Both were double-blindly assessed with the SAPS, SANS, BPRS and TESS, before and after treatment, to evaluate the effects on positive and negative symptoms.

Insights and treatment compliance were assessed with the Brief Psychiatric Rating Scale ( BPRS) and Insight and Treatment Attitude Questionnaire ( ITAQ) in 1 st week of admission.

两组在入院1w内和出院时采用简明精神病评定量表、自知力与治疗态度问卷及服药依从性进行评定和对比分析。

Method: 146 first-episode schizophrenic patients were evaluated with BPRS before and after treatment, then 18 items of BPRS were conducted factor analysis, item analysis and computed Cronbach alpha.

方法：对首发精神分裂症患者在治疗前后分别评定BPRS，然后对其18个项目进行因子分析、项目分析和计算Cronbachα值。

The patients were assessed by brief psychiatric rating scale ( BPRS), inpatient psychiatric rehabilitation outcome scale ( IPROS) and general self-efficacy scale ( GESE).

评定工具用简明精神病评定量表（BPRS）、住院精神病人康复疗效评定量表（IPROS）和自我效能感量表（GESE）进行对照评定分析。

The total scores of the BPRS 、 SAPS 、 and SANS in clozapine group at endpoint were significantly smaller than that of chlorpromazine group ( P < 0.01);

疗后氯氮平组的BPRS、SAPS、SANS总分均明显低于氯丙嗪组（P＜0.01）；

Efficacy and safety of the treatment were assessed respectively by Brief Psychiatric Rating Scale ( BPRS), treatment-emergent signs and symptoms ( TESS), ECG, liver renal function.

以治疗前后简明精神病量表（BPRS）激越分的减分率评定疗效，以副反应量表（TESS）及心电图及肝肾功能评价安全性。

Results In the 6th and 12th month after being discharged from hospital, the score of the BPRS of the follow-up group was lower than the control group ( P < 0.01).

结果出院6、12个月时家访组病人BPRS评分明显低于对照组（P

The results showed that zuclopenthixol acetate can effectively control acute psychotic symptoms, BPRS amelioration expressed marked improvement rate of clinical symptoms is 30. 2%, improvement rate 62.3%.

结果显示：该药能有效地控制急性精神症状，BPRS减分率显示显好率是30.2%，好转率为62.3%；

All cases were assessed by brief psychiatric rating scale ( BPRS), Hamilton anxiety scale ( HAMA), and Hamilton depression scale ( HAMD).

用简明精神病评定量表（BPRS）、Hamilton抑郁量表（HAMD）、Hamilton焦虑量表（HAMA）进行评定。

Methods: 140 cases of psychiatric in-patients randomly arrange to painting therapy group and control group. BPRS and SFRS were applied to assess the effect before and after treatment.

方法：140例男性住院精神病患者随机分为绘画治疗组和对照组，采用症状评定（BPRS）量表和社会功能评定（SFRS）量表得分的变化评估治疗效果。

Method: 32 patients with first episode schizophrenia were treated with olanzapine for 8 weeks, and assessed with BPRS and TESS for the efficacy and safety.

方法用奥氮平治疗首发精神分裂症32例，疗程8周；用简明精神病评定量表（BPRS）和副反应量表（TESS）评定疗效及副反应。

Psychiatric interview and physical examination completely, assessment for BPRS, GAS, SDSS, making out psychiatric diagnosis and assessment disability rank of mental disease exactly.

全面精神及体格检查，BPRS、GAS、SDSS等量表评定，作出疾病诊断，对相关残情进行准确的等级评定。

Results: The scores of BPRS of painting therapy group is better than control group. But there is no statistic difference between the scores of SFRS of two groups.

结果：绘画治疗组治疗后症状评定（BPRS）量表得分要优于对照组，差异有统计学意义，但两组社会功能评定量表得分差异无统计学意义。

QOLS, IPROS, BPRS and SANS were used to evaluate the efficacy before treatment and 8 weeks after treatment and to analyze associated factors.

治疗8周。于治疗前后分别以QOLS、IPROS、BPRS、SANS量表进行疗效评定及相关因素分析。

Results The reduction of scores of BPRS, SDSS, ADL and bone minerals test in Morita Therapy group were significantly more than that in controls.

结果森田疗法组的BPRS、SDSS、ADL评分和骨矿物质含量结果明显优于对照组。

Method Patients with first-onset schizophrenia were treated with risperidone for 12 weeks, and assessed with BPRS and TESS for the efficacy and side effect.

方法单独使用维思通治疗连续住院的首发精神分裂症12周，用BPRS和TESS量表评定疗效和副反应。

Result After the rehabilitation training, score of IPROS, BPRS and sub scale were decreased after treatment ( P < 0.05~ 0.01).

结果经康复训练后IPROS、BPRS总分及分量表分均低于治疗前（P

Compared with baseline, the scores of PANSS and BPRS in endpoint were significantly reduced in both groups ( P < 0.05).

治疗结束时，2组PANSS和BPRS评分较入组时均显著减低（P＜0.05）；

BPRS showing that the factor scores of lack vitality were obviously higher than those of activation and hostile suspicion ( P < 0 05);

BPRS示缺乏活力因子分明显高于激活性及敌对猜疑因子分（P均

BPRS, CGI and TESS were adopted to evaluate the efficacy and side effects before and after 2,4 and 6 weeks of the treatment.

疗程6周，于治疗前及治疗第2、4、6周末进行简明精神病评定量表（BPRS）、临床疗效总评量表（CGI）评定疗效，用副反应量表（TESS）评定不良反应。

All patients were assessed using BPRS in pre-treatment, post-treatment 1,2,4 and 8 week, and assessed using TESS after 8 week.

经8周治疗在治疗前、治疗后的1、2、4、8周应用简明精神病量表（BPRS）评定疗效，在8周后做副反应量表（TESS）评定不良反应。